Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
domenica, ottobre 11
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Processa Pharmaceuticals Inc
PCSA
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$1.52
0.17
12.59%
Ult. Agg.: Oct 9, 7:34 PM
$1.46
0.11
8.15%
Get Report
Panoramica
Notizie
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Rapporto azionario
Privacy Manager
Processa Pharma Financials
Processa Pharma (PCSA) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Processa Pharma Q2 EPS $(0.25) Misses $(0.20) Estimate
Processa Pharma (NASDAQ:PCSA) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.20) by 25 percent. This is a 75.25 percent increase over losses of $(1.01) per share from
Benzinga Newsdesk
Crude Oil Rises Sharply; Jabil Earnings Top Views
Avi Kapoor
PRO
Processa Pharma Q3 2024 GAAP EPS $(1.03) Misses $(1.00) Estimate
Processa Pharma (NASDAQ:PCSA) reported quarterly losses of $(1.03) per share which missed the analyst consensus estimate of $(1.00) by 3 percent.
Benzinga Newsdesk
Constellation Brands, Levi Strauss And 3 Stocks To Watch Heading Into Thursday
Avi Kapoor
PRO
Processa Pharma Q2 EPS $(1.01) Beats $(1.02) Estimate
Processa Pharma (NASDAQ:PCSA) reported quarterly losses of $(1.01) per share which beat the analyst consensus estimate of $(1.02) by 0.98 percent. This is a 49.5 percent increase over losses of $(2.00) per share from the
Benzinga Newsdesk
Nasdaq Down 1%; JetBlue Airways Shares Spike Higher
Avi Kapoor
